| 1 |
Jiang H, Chen H, Wan P, Liang M, Chen N. Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro. J Inflamm Res 2021;14:6421-30. [PMID: 34880644 DOI: 10.2147/JIR.S341596] [Reference Citation Analysis]
|
| 2 |
Zhao S, Zhang X, Chen S, Zhang S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discov 2021;7:283. [PMID: 34635646 DOI: 10.1038/s41420-021-00678-8] [Reference Citation Analysis]
|
| 3 |
Wo L, Zhang B, You X, Hu Y, Gu Z, Zhang M, Wang Q, Lv Z, Zhao H. Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells. Immunopharmacol Immunotoxicol 2022;:1-8. [PMID: 35332839 DOI: 10.1080/08923973.2022.2054428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Yang T, Wang Y, Liao W, Zhang S, Wang S, Xu N, Xie W, Luo C, Wang Y, Wang Z, Zhang Y. Down-regulation of EPB41L4A-AS1 mediated the brain aging and neurodegenerative diseases via damaging synthesis of NAD+ and ATP. Cell Biosci 2021;11:192. [PMID: 34758883 DOI: 10.1186/s13578-021-00705-2] [Reference Citation Analysis]
|
| 5 |
Wang P, Chen Y, Zheng Y, Fu Y, Ding Z. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma. Dis Markers 2021;2021:5340240. [PMID: 34712369 DOI: 10.1155/2021/5340240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Rudzinska M, Czarnecka-Chrebelska KH, Kuznetsova EB, Maryanchik SV, Parodi A, Korolev DO, Potoldykova N, Svetikova Y, Vinarov AZ, Nemtsova MV, Zamyatnin AA Jr. Long Non-Coding PROX1-AS1 Expression Correlates with Renal Cell Carcinoma Metastasis and Aggressiveness. Noncoding RNA 2021;7:25. [PMID: 33920185 DOI: 10.3390/ncrna7020025] [Reference Citation Analysis]
|
| 7 |
Adylova A, Mukhanbetzhanovna AA, Attar R, Yulaevna IM, Farooqi AA. Regulation of TGFβ/SMAD signaling by long non-coding RNAs in different cancers: Dark Knight in the Castle of molecular oncology. Noncoding RNA Res 2021;6:23-8. [PMID: 33511320 DOI: 10.1016/j.ncrna.2020.12.003] [Reference Citation Analysis]
|
| 8 |
Zhou Y, Zhang Z, Wo M, Xu W. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis. Bioengineered 2021;12:8994-9005. [PMID: 34643163 DOI: 10.1080/21655979.2021.1992330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
